Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.51 |
| ▸ | ACR | P10323 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | ERN1 | O75460 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15948378 | 0.89 | CA1 (0.61) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL18121555 | 0.89 | CA1 (0.61) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL19021126 | 0.87 | CA1 (0.56) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL18329185 | 0.87 | CA1 (0.62) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL13859676 | 0.87 | LMNA (0.68) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL16604902 | 0.87 | LMNA (0.68) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL14817293 | 0.87 | LMNA (0.68) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL8983994 | 0.84 | ESR2 (0.66) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL14877890 | 0.84 | ESR2 (0.66) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL22109034 | 0.84 | ESR2 (0.66) | LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170174992-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, COMPOSITION, LIQUID CRYSTAL POLYMERIZATION FILM-KIND THEREOF AND USE THEREOF | JNC CORPORATION (JP) | 2017-06-22 | — | — | US | disclosed |
| US-9540567-B2 | Polymerizable liquid crystal composition and optically anisotropic body | JNC CORPORATION (JP) | 2017-01-10 | — | — | US | disclosed |
| US-20160369166-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND OPTICAL ANISOTROPICAL BODY THEREOF | JNC CORPORATION (JP) | 2016-12-22 | — | — | US | disclosed |
| US-20160289562-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND OPTICALLY ANISOTROPIC BODY | JNC CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174992-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, COMPOSITION, LIQUID CRYSTAL POLYMERIZATION FILM-KIND THEREOF AND USE THEREOF | RCC1, CHRM1, PFN1 | LMNA 432/4885CYP1A2 703/4885CYP2C9 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.